Please assess the completion status of the following clinical trial:

Trial Title: Low-dose Colchicine With or Without Stepwise Dose Titration of Febuxostat for Flare Prophylaxis in Gout

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Ages Eligible for Study: more than 20 years~Inclusion Criteria:~1. Hyperuricemia (serum urate ≥7.0 mg/dL and gout by 1977 American College of Rheumatology Criteria~2. Acute gout attack during the last 12 months~Exclusion Criteria:~1. Acute gout attack in the last 2 weeks~2. Urate-lowering therapy in the last 4 weeks~3. Secondary hyperuricemia~4. Creatinine ≥2.0 mg/dL~5. AST or ALT ≥2x upper limits of normal~6. Heart failure (NYHA III-IV)~7. Hypersensitivity to colchicine, NSAID or febuxostat~8. Use of NSAID, glucocorticoid, cyclosporine, clarithromycin, mercaptopurine, azathioprine, pyrazinamide, ethambutol, chemotherapy, tacrolimus, losartan, and fenofibrate~9. Inability to comply with the protocol requirements~10. The judgement of the investigator that the patient was not an appropriate candidate

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: 100 Years
- Healthy Volunteers: f

Study Arms:
- Dose titration group (Type: EXPERIMENTAL): Stepwise dose titration of febuxostat and low-dose colchicine
- Standard treatment group (Type: ACTIVE_COMPARATOR): Fixed dose febuxostat and low-dose colchicine

Based on this trial design, predict the completion outcome and termination type (if applicable).